News

Our latest news and announcements

Vaccine Development at CPI

The World’s population is facing increased threats of disease from pathogens. Whether it is an influenza pandemic or outbreak such as the recent Ebola crisis in Africa or diseases such as Malaria or Severe Acute Respiratory Syndrome (SARS), the need for cheaper, effective vaccines is on the rise. Thanks to advances in medicine, we can now use viruses to treat disease, and it’s this area of vaccine development where CPI can help.

Nov 14 2019

An update on the Medicines Manufacturing Innovation Centre

Since we made the announcement last year that CPI would be one of the collaborative partners in delivering the new Medicines Manufacturing Innovation Centre, the team have been working tirelessly to engage with industry and drive projects forward.

Nov 14 2019

CPI to showcase new flexible electronics capabilities to end-users at industry event

CPI today announced that an event will take place on 27 – 28 November 2019, to showcase the outcomes of project Necomada (Nano-Enabled Conducting Materials Accelerating Device Applicability)

Nov 06 2019

New project supports the development of innovative products and processes through additive manufacturing

CPI has announced a new project offering flexible access to innovation facilities and expertise in commercialising new products and processes in the additive manufacturing and coating industries.

Oct 28 2019

CPI accelerates gene therapy development with robust adeno-associated virus purification system

CPI today announces the success of its CRD IUK project to develop a scalable, cost-effective purification process for adeno-associated viruses (AAVs), in partnership with Cobra Biologics and GE Healthcare Life Sciences. The new process will remove a significant bottleneck in the development of gene therapies, and enable these innovative products to be brought to market more quickly.

Oct 17 2019

The Medicine Manufacturing Innovation Centre to develop platform for quicker optimisation of oral solid drug formulations

CPI and the University of Strathclyde, in strategic partnership with GSK and AstraZeneca, today announced a new platform that will enable oral solid dosage medicines to be formulated more robustly and efficiently.

Oct 09 2019

Development of an In-House Cell Free Extract Process and Robotic Platform for Expression Optimisation

The advent of personalised medicine promises more efficacious treatments. However, moving away from a one size fits all’ model demands new, adaptable and complex manufacturing processes for the next generation of therapeutics.

Oct 03 2019

Successful workshop maps out future for the Medicines Manufacturing Innovation Centre

An array of industry experts, equipment suppliers, government and academia came together recently in Glasgow for a two-day, Road Mapping Workshop for the new Medicines Manufacturing Innovation Centre

Sep 26 2019

CPI and EU partners create commercialisation support for photonics

Small and Medium-sized Enterprises (SMEs) working with photonics in life sciences markets can benefit from the support offered by CPI and other European partners, as part of the Horizon 2020 project EPRISE (Empowering Photonics through Regional Innovation Strategies in Europe).

Sep 18 2019
Next  
1 2 3 Next  

Page 1 of 57